Associate Professor, Internal Medicine, Mayo Medical School
Hematology
Dr. Michelle A. Elliott, MD
|
|
Give Review
Michelle A. Elliott works in the field of Hematology. Doctor Michelle A. Elliott, MD has written publications. She has 72 publications published with PubMed. The lastest publication is: 'Splenic irradiation for symptomatic splenomegaly associated with myelofibrosis with myeloid metaplasia.'
Publications
- Chronic neutrophilic Leukemia 2016: Update on diagnosis, molecular genetics, prognosis, and management.
- Chronic neutrophilic Leukemia: novel mutations and their impact on clinical practice.
- Outcomes of plasma exchange in patients with transplant-associated thrombotic microangiopathy based on time of presentation since transplant.
- Chronic neutrophilic Leukemia 2014: Update on diagnosis, molecular genetics, and management.
- CALR mutation studies in chronic neutrophilic Leukemia.
- Chronic neutrophilic Leukemia with concurrent CSF3R and SETBP1 mutations: single colony clonality studies, in vitro sensitivity to JAK inhibitors and lack of treatment...
- The molecular genetics of Chronic neutrophilic leukaemia: defining a new era in diagnosis and therapy.
- CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic Leukemia.
- Therapy-related Acute promyelocytic leukemia (t-APL): Observations relating to APL pathogenesis and therapy.
- A Phase II study of (153)Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple Myeloma.
- Thrombotic microangiopathy during peripheral blood stem cell mobilization.
- Autologous stem cell transplant in 716 patients with multiple Myeloma: low treatment-related mortality, feasibility of outpatient transplant, and effect of a multidisc...
- Early peripheral blood blast clearance during induction chemotherapy for Acute myeloid leukemia predicts superior relapse-free survival.
- MPL515 mutations in myeloproliferative and other Myeloid disorders: a study of 1182 patients.
- Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation.
- Respective clustering of unfavorable and favorable cytogenetic clones in myelofibrosis with Myeloid metaplasia with homozygosity for JAK2(V617F) and response to erythr...
- Atypical myeloproliferative Disorders: diagnosis and management.
- "Myelodysplasia," myeloneuropathy, and copper deficiency.
- Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral bl...
- Pathogenesis and management of bleeding in essential thrombocythemia and Polycythemia vera.
- Durable responses to thalidomide-based drug therapy for myelofibrosis with Myeloid metaplasia.
- Schistocytes on the peripheral blood smear.
- Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control study.
- Chronic neutrophilic Leukemia: a contemporary review.
- Apparent failure of moxifloxacin to prevent ciprofloxacin- and levofloxacin-susceptible Pseudomonas aeruginosa bacteremia in neutropenic patients undergoing peripheral...
- Posttransplantation thrombotic Thrombocytopenic purpura: a single-center experience and a contemporary review.
- Phase 2 trial of imatinib mesylate in myelofibrosis with Myeloid metaplasia.
- Adverse events after imatinib mesylate therapy.
- A phase I study of 153Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple Myeloma.
- Lonafarnib reduces the resistance of primitive quiescent CML cells to imatinib mesylate in vitro.
- Risk-adjusted manipulation of melphalan dose before stem cell transplantation in patients with amyloidosis is associated with a lower response rate.
- Autologous HSC transplant in t-MDS/AML using cells harvested prior to the development of the Secondary malignancy.
- Phase I trial of autologous hematopoietic SCT with escalating doses of topotecan combined with CY and carboplatin in patients with relapsed or persistent ovarian or pr...
- Fechtner Syndrome: physiologic analysis of macrothrombocytopenia.
- Amifostine alone and in combination with erythropoietin for the treatment of favorable myelodysplastic Syndrome.
- Low risk of symptomatic Venous thromboembolic events during growth factor administration for PBSC mobilization.
- Monocytosis is an adverse prognostic factor for survival in younger patients with primary myelofibrosis.
- Disseminated nocardiosis after allogeneic bone marrow transplantation.
- Immunophenotypic normalization of aberrant mast cells accompanies histological remission in imatinib-treated patients with eosinophilia-associated mastocytosis.
- JAK2 germline genetic variation affects Disease susceptibility in primary myelofibrosis regardless of V617F mutational status: nullizygosity for the JAK2 46/1 haplotyp...
- WHO-defined chronic neutrophilic Leukemia: a long-term analysis of 12 cases and a critical review of the literature.
- Splenectomy in chronic myeloid Leukemia and myelofibrosis with myeloid metaplasia.
- Allogeneic stem cell transplantation and donor lymphocyte infusions for chronic myelomonocytic Leukemia.
- New drugs in essential thrombocythemia and Polycythemia vera.
- Interferon-alpha therapy in Polycythemia vera and essential thrombocythemia.
- Thrombosis in myeloproliferative Disorders: prevalence, prognostic factors, and the role of leukocytes and JAK2V617F.
- Chronic neutrophilic Leukemia (CNL): a clinical, pathologic and cytogenetic study.
- CD34+ cell dose and establishment of full donor chimerism at day +100 are important factors for survival with reduced-intensity conditioning with fludarabine and melph...
- Chronic lymphocytic leukaemia with symptomatic diffuse central nervous system infiltration responding to therapy with systemic fludarabine.
- Hydroxyurea-induced marked oscillations of platelet counts in patients with Polycythemia vera.
- The effect of absolute lymphocyte count recovery kinetics on survival after autologous stem cell transplantation for non-Hodgkin''s Lymphoma.
- Thalidomide in myelofibrosis with Myeloid metaplasia: a pooled-analysis of individual patient data from five studies.
- Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia.
- Splenic irradiation in myelofibrosis with Myeloid metaplasia: a review.
- A phase 2 trial of combination low-dose thalidomide and prednisone for the treatment of myelofibrosis with Myeloid metaplasia.
- FIP1L1-PDGFRA in eosinophilic Disorders: prevalence in routine clinical practice, long-term experience with imatinib therapy, and a critical review of the literature.
- The clinical phenotype of wild-type, heterozygous, and homozygous JAK2V617F in Polycythemia vera.
- Splenic irradiation for symptomatic splenomegaly associated with myelofibrosis with Myeloid metaplasia.
- Thrombotic thrombocytopenic purpura and hemolytic uremic Syndrome.
- A phase II trial of pirfenidone (5-methyl-1-phenyl-2-[1H]-pyridone), a novel anti-fibrosing agent, in myelofibrosis with Myeloid metaplasia.
- The prognostic significance of trisomy 8 in patients with Acute myeloid leukemia.
- Thalidomide treatment in myelofibrosis with Myeloid metaplasia.
- Thrombocythaemia and pregnancy.
- FIP1L1-PDGFRA and c-kit D816V mutation-based clonality studies in systemic mast cell Disease associated with eosinophilia.
- Thromboembolism in adults with Acute lymphoblastic leukemia during induction with L-asparaginase-containing multi-agent regimens: incidence, risk factors, and possible...
- Neutrophil polycythemia rubra vera-1 expression in classic and atypical myeloproliferative Disorders and laboratory correlates.
- Chronic neutrophilic Leukemia and chronic myelomonocytic Leukemia: WHO defined.
- Peripheral blood stem cell transplant for POEMS Syndrome is associated with high rates of engraftment Syndrome.
- Long-term outcome of allogeneic stem cell transplantation in chronic lymphocytic Leukemia: analysis after a minimum follow-up of 5 years.
- Cancer-associated microangiopathic hemolytic Anemia with thrombocytopenia: an important diagnostic consideration.
- Thrombosis in myelofibrosis: prior Thrombosis is the only predictive factor and most venous events are provoked.
Schools
University of Dublin Trinity College School of Physic
St James Hospital
Mayo Clinic Rochester
Procedures Preformed
- Plasmapheresis
Conditions Treated
- Acute Leukemia
- Anemia
- Antiphospholipid Syndrome (APS)
- Breast Cancer
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Hospital
-
Mayo Clinic - Rochester, Minnesota
Drug Facts
| NPI NUMBER | 1740266543 | |
| NPPES Provider LastName | ELLIOTT | |
| NPPES Provider FirstName | MICHELLE | |
| NPPES Provider ZIPCode | 559050001 | |
| NPPES Provider State | MN | |
| Specialty Description | Hematology | |
| Total Claim Count | 224.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1740266543 |
| Last Name Of The Provider | ELLIOTT |
| First Name Of The Provider | MICHELLE |
| View All |
Similar Doctors
|
|
Dr. Jeremy T. Larsen, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Morie A. Gertz, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Thomas E. Witzig, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Suzanne R. Hayman, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Andrea E. Wahner Hendrickson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kostandinos Sideras, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert R. McWilliams, MD |
|
|
Dr. Luis F. Porrata, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Konstantinos Leventakos, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Minetta Liu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Morris A. Gertz |